Here’s Who Picked Nivalis Therapeutics Inc. (NASDAQ:NVLS) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Nivalis Therapeutics Inc. (NASDAQ:NVLS) reported that Flynn James E has picked up 3,732,414 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Flynn James E to a total of 3,732,414 representing less than 23.84% stake in the company.
For those not familiar with the company, Nivalis Therapeutics, Inc. is a pharmaceutical company. The Company focuses on the discovery and development of product candidates for patients with cystic fibrosis (CF). Its drug candidate portfolio consists of multiple compounds, which are designed for oral, intravenous (IV) or inhaled administration. The Company’s S-nitrosoglutathione reductase (GSNOR) inhibitors selectively target GSNOR. Depleted levels of S-nitrosoglutathione (GSNO) have been associated with CF, asthma, inflammatory bowel diseases and certain cardiovascular diseases. The Company’s lead product candidate, cavosonstat (N91115), is a small molecule inhibitor of GSNOR. cavosonstat is a pill that is in two Phase II clinical trials intended to address a defect in CF transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR gene. Its preclinical studies have shown that cavosonstat is a selective and reversible inhibitor of GSNOR.
A glance at Nivalis Therapeutics Inc. (NASDAQ:NVLS)’s key stats reveals a current market capitalization of 30.58 Million based on 15.66 Million shares outstanding and a price at last close of $2.10 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-02, Carruthers picked up 24,000 at a purchase price of $2.09. This brings their total holding to 24,000 as of the date of the filing.
On the sell side, the most recent transaction saw Rodman unload 6,687 shares at a sale price of 2.27. This brings their total holding to 11,368.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Nivalis Therapeutics Inc. (NASDAQ:NVLS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Jerrick Media Holdings Inc. (OTCMKTS:JMDA) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Jerrick Media Holdings Inc. (OTCMKTS:JMDA) reported that Gordon Christopher P. has picked up 10,555,246 of common stock as of 2017-04-25.
The acquisition brings the aggregate amount owned by Gordon Christopher P. to a total of 10,555,246 representing less than 24.1% stake in the company.
For those not familiar with the company, Jerrick is a technology and digital media company focused on the development of communities, marketing branded digital content, and e-commerce opportunities.
A glance at Jerrick Media Holdings Inc. (OTCMKTS:JMDA)’s key stats reveals a current market capitalization of 4.42 Million based on 33.98 Million shares outstanding and a price at last close of $0.135 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2013-09-26 Campbell picked up 5,000,000 at a purchase price of $0.32. This brings their total holding to 6,466,225 as of the date of the filing.
On the sell side, the most recent transaction saw Frommer unload 100,000 shares at a sale price of $0.25. This brings their total holding to 11,494,884.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Jerrick Media Holdings Inc. (OTCMKTS:JMDA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Why NOHO Inc (OTCMKTS:DRNK) Shares Popped 14% Higher
NOHO Inc (OTCMKTS:DRNK) shares were up 14.29% on Monday to $0.00040 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.00. The company has a market cap of $2.87 million at 656.04 million shares outstanding.
NOHO Inc is a company that develops, markets, sells and distributes a beverage category product named NOHO – The Hangover Defense (NOHO). Its flagship product NOHO is a dietary supplement, which is taken before and after the consumption of alcohol that helps to prevent the symptoms associated with a hangover.
NOHO is formulated by a Doctor of Pharmacy and comes in a 2 ounce shot. It is recommended that the 2 ounce shot be taken before and after drinking any alcoholic beverages. NOHO has a flavor, which contains no caffeine or stimulants. It has also launched NOHO Gold, which is a premium lifestyle beverage that is developed and marketed as a healthy beverage. NOHO Gold is offered to and sold in premier nightclubs On Premise bar and club venues in the United States including the Fontainebleau Hotel, LIV nightclub, Story nightclub, Day Light, Light, The Opium Group properties, and others.
In a press release, NOHO Inc announced that it has reached an agreement in principle with its 95% majority convertible note holder for a moratorium on conversions, relating to notes issued after March 7, 2015. Apart from this, it will also maintain its ability to retire the outstanding notes in cash.
“We have come to terms with our majority note holder to freeze conversions, which puts NOHO in a very strong position moving forward with significant developments underway. This is a strong signal of our majority debt holders confidence in the long term vision we have for the Company. This agreement is also a big win for our shareholders, as we continue to make changes to reduce the outstanding shares and avoid dilution as a priority moving forward,” said NOHO Inc CEO David Mersky.
Under the terms of this agreement, NOHO Inc will be forming a financial services division wherein a percentage of top line revenues will be allocated toward funding the debt repurchase plan. Details have yet to be announced before May 31, 2017. Note that if the notes subject to the freeze are not repurchased by NOHO Inc, there will be a restriction of stock sales, subject to a lockdown and leakout agreement, which is currently being finalized.
Prior to this, NOHO Inc announced the signing of a national sales and distribution agreement with BNG Enterprises, Inc. in Arizona for the exclusive rights to sell the NOHO 2oz Shot in its nationwide retail stores as well as online sales through Amazon.
NOHO is proud to announce this deal with BNG Enterprises and is excited to begin moving product into retail stores across the country. In addition to its core strength in selling to retail smoke shops and vape stores, where NOHO is a natural fit, BNG also has established relationships with big box retailers, convenience stores and the supermarket space. This deal brings NOHO the ability to manufacture, warehouse and ship product through a well-established sales and distribution partner with a stellar reputation. This is just the beginning of what we envision to be a long-term relationship,” noted CEO Mersky.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.